Live

Oracle Corporation Common Stock (ORCL) congressional disclosures

Technology · coverage Jan 26, 2024–Aug 7, 2026

Create a ORCL watch
Tracked disclosures
40
Lawmakers
16
Reported purchase / sale rows
22 / 18A disclosure count, not congressional market sentiment

Estimated market comparison · not an official filing fact

Available with Pro

Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.

Disclosure alert preview

Based on a real public filing

Purchase

Michael A. Rulli

ORCLOracle Corporation Common Stock

$1K - $15K

Traded
Jan 14, 2025
Filed
Aug 7, 2026
Disclosure delay
570 days
Reported owner
Not normalized

This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Aug 13, 2026.

Official filing

ORCL congressional trades snapshot

This page summarizes public STOCK Act disclosures involving ORCL. It is useful for seeing which lawmakers reported ORCL transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Aug 7, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the ORCL congressional trade page shows

Congressional Trader tracks 40 public STOCK Act disclosures for ORCLacross 16 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent ORCL filing shown here was filed on Aug 7, 2026 by Michael A. Rulli as a purchase. Related lawmakers include Jared Moskowitz, Jefferson Shreve, Lisa C. McClain, Robert P. Bresnahan, Cleo Fields.

FAQ

Which lawmakers traded ORCL?

Recent ORCL disclosures include Jared Moskowitz, Jefferson Shreve, Lisa C. McClain, Robert P. Bresnahan, Cleo Fields.

What is the buy/sell mix for ORCL?

The visible sample currently shows 22 purchases and 18 sales or partial sales.

Should I trade based on ORCL disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.